Irish drugmaker Elan ( ELN) said its fourth-quarter earnings totaled 56 cents a share, in line with the consensus estimate and up from 45 cents a share in the year-ago period, but the company warned that earnings for 2002 will come in below expectations.

Revenue for the fourth quarter rose 15% to $487.6 million from $424.4 million in the year-ago period, but fell short of the consensus estimate of $524.4 million.

For 2002, the drug company said it expects earnings to be affected by lower revenue because of the delay of new products. The company expects earnings of $1.55 to $1.65 a share on revenue of $2 billion to $2.1 billion. Analysts had been expecting $2.35 a share on revenue of $2.32 billion.

Shares of Elan were recently trading down 23.2% to $23 in Instinet premarket action after closing at $29.95 Friday.

If you liked this article you might like

Stocks to Watch: Ann Taylor Climbs, Electronics Sellers Drop

Stocks to Watch: Ann Taylor Climbs, Electronics Sellers Drop

Tough Month, Better Quarter for Retailers

Tough Month, Better Quarter for Retailers

AON Plunges on Accounting Issues, Earnings

AON Plunges on Accounting Issues, Earnings

Stocks to Watch: TiVo Climbs on Guidance, Cross Country Plunges

Stocks to Watch: TiVo Climbs on Guidance, Cross Country Plunges

Polo Posts Lower First-Quarter Results

Polo Posts Lower First-Quarter Results